News und Analysen

Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies and cytokines for the treatment of cancer and autoimmune diseases, today announced

Regulatory News:

Vifor Pharma Group reported stable net sales and a continued strong increase in profitability in 2020, despite challenges to patient access from COVID-19 and the impact of a much

Regulatory News:

Die Vifor Pharma Gruppe weist auch für 2020 trotz des durch COVID-19 erschwerten Patientenzugangs und den Folgen des gegenüber dem US-Dollar deutlich stärkeren Schweizer Franken

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) gab heute die weltweite Einführung von QIAcube Connect MDx bekannt, einer flexiblen Plattform für die automatisierte Probenverarbeitung, die

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the global launch of the QIAcube Connect MDx, a flexible platform for automated sample processing that will now be available

Premier Inc. (NASDAQ: PINC), a leading healthcare improvement company, today acquired substantially all the assets and certain liabilities of Invoice Delivery Services, LP (IDS), a leading provider

Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced financial results for the fourth quarter and year ended December 31, 2020.

On January 19, 2021, the Company closed on the sale of

Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that the Company will participate in the Raymond James 42^nd Annual Institutional Investors Conference, which is being held as a

Charles River Laboratories International, Inc. (NYSE: CRL) today announced a strategic partnership with Kibur Medical to offer exclusive access to its implantable microdevice (IMD) for in vivo

Novocure (NASDAQ: NVCR) today reported financial results for the quarter and full year ended December 31, 2020, highlighting revenue growth and financial strength as well as the advancement of the

Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies and cytokines for the treatment of cancer and autoimmune diseases, and UCLA

Genus plc (LSE: GNS), a global biotechnology leader in animal genetics, today reported interim results for the six-months period ending December 31, 2020, as well as provided a business update on

Premier Inc. (NASDAQ: PINC), a leading healthcare improvement company, has been named one of the 2021 World’s Most Ethical Companies by the Ethisphere® Institute, a global leader in defining and

ICON plc, (NASDAQ: ICLR), a global provider of outsourced drug and device development and commercialisation services to the pharmaceutical, biotechnology and medical device industries, and

LivaNova PLC (NASDAQ: LIVN), a market-leading medical technology and innovation company, today reported results for the quarter and full-year ended December 31, 2020.

For the fourth quarter of

ICON plc (NASDAQ: ICLR), a global provider of outsourced drug and device development and commercialisation services to pharmaceutical, biotechnology, medical device and government and public health

QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) und INOVIO Pharmaceuticals (NASDAQ: INO) gaben heute die Erweiterung ihrer Partnerschaft durch einen neuen Rahmenvertrag zur Entwicklung von

QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) and INOVIO Pharmaceuticals (NASDAQ: INO) today announced an extension of their partnership with a new master collaboration agreement to develop

Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies and cytokines for the treatment of cancer and autoimmune diseases, today reported

Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest

QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) gab heute die Berufung von Thomas Ebeling mit sofortiger Wirkung zum Mitglied des Aufsichtsrats bekannt. Herr Ebeling ist eine internationale

QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today the appointment of Thomas Ebeling, a leading international executive with extensive experience in the healthcare, media and

Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has declared a quarterly cash dividend of 34-cents per share on the Company’s capital stock, payable on March 19, 2021, to

AMN Healthcare Services, Inc. (NYSE: AMN), the leader and innovator in total talent solutions for healthcare organizations across the United States, today announced its fourth quarter and full year

Premier Inc. (NASDAQ: PINC), a leading healthcare improvement company, announced today that members of its management team are scheduled to present at the 10^th Annual SVB Leerink Global Healthcare